Skip to main content

Implantable heart plug reduces threat of stroke in people with irregular heartbeats

There’s a little pouch with no known purpose that protrudes off the top chamber of people’s hearts that can increase risk of stroke among those with irregular heartbeats. But local doctors are addressing the situation with a permanent implant that plugs the pouch’s hole.

“Everyone has the pouch. But those patients who have atrial fibrillation, we know that those patients have a fivefold higher risk of having a stroke,” said Dr. Manish Shah, director of the Cardiac Electrophysiology Fellowship Training Program at MedStar Washington Hospital Center.

People with atrial fibrillation can have strokes when blood clots form inside of the pouch.

But the pouch opening can be blocked with what’s called a Watchman device that’s inserted with a small catheter; it functions much like an umbrella and pops open to seal the hole.

“Afterward, the patients have to just lay flat for a few hours and then actually get to go home the same day,” Shah said. “There’s no cutting involved. There’s no major surgery involved. This is really a very minimally invasive, nonintrusive procedure for our patients, and they’re enormously thankful after they’ve had it done.”

The technology is relatively new. In 2015, MedStar Washington Hospital Center was the first hospital in the D.C. region to implant a Watchman device successfully.

The procedure also is being performed at MedStar Union Memorial in Baltimore, making MedStar Health the first health care system in the Greater Washington-Baltimore region to implant 700 of the Watchman devices.

Patients eligible for the procedure are typically not doing well with blood thinners used to prevent stroke.

“There are some new interesting studies where we’re taking patients who are doing just fine with a blood thinner who have atrial fibrillation, and we’re then offering those patients a replacement for their blood thinner with the Watchman device,” Shah said. “And that’s a new interesting area that I think we’re going to learn a lot about over the next five years.”

Atrial fibrillation affects as many as 6 million Americans, a number Shah said is expected to double over the next decade, as the baby boomer portion of the population gets older.

“As we get a little bit older, unfortunately, we’re all going to have a higher chance of having atrial fibrillation over time,” Shah said.

Warning signs of an irregular heartbeat include palpitations, a racing heartbeat, feeling a flip- flopping sensation in the chest, having periods of the time feeling fatigued or just not feeling well.

Shah said to help an atrial fibrillation diagnosis, devices, such as smartwatches, can be attached to smart phones to record an EKG when someone’s feeling symptoms.

“Heart rhythm atrial fibrillation can come and go; you’re not always in that heart rhythm. And so sometimes it can be a little tricky for us to catch. But once we’ve got it, we know what to do,” Shah said.

States seek to lower drug prices by targeting the companies that manage them for health plans

TOPEKA, Kan. (AP) — As consumers worry about medication costs, states are trying to lower drug prices by reining in big companies that oversee prescription coverage for health insurers. Some of those companies, called pharmacy benefit managers, also own pharmacies, and one of them, CVS, has spent millions of dollars fighting the regulations. Affordability is a key issue ahead of this year’s midterm elections. Legislators in at least a dozen states passed laws this year to limit compensation to the companies, set minimum payments from the companies to pharmacists and require the companies to disclose more information to their clients, states and the public. A Tennessee law will bar pharmacy benefit managers from operating retail pharmacies as of July 1, 2028, though CVS Health Corp. has filed a federal lawsuit to avoid having to close its 136 pharmacies there.
Read Next Story